Parotidectomy: Ten-year review of 237 cases at a single institution

被引:112
作者
Upton, David C.
McNamar, Justin P.
Connor, Nadine P.
Harari, Paul M.
Hartig, Gregory K.
机构
[1] Univ Wisconsin Hosp & Clin, Dept Surg, Div Ototlaryngol, Madison, WI 53792 USA
[2] Univ Wisconsin Hosp & Clin, Dept Human Oncol, Madison, WI 53792 USA
关键词
D O I
10.1016/j.otohns.2006.11.037
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE: To review a single surgeon's experience with parotidectomy with an emphasis on examining the appropriate use of partial superficial parotidectomy and the differences in early outcomes observed with the various types and extent of parotidectomy used. STUDY DESIGN AND SETTING: A series of 237 patients who underwent parotidectomy over a 10-year period was reviewed. RESULTS: Postoperative complications included facial nerve weakness (18%), sialocele (6.3%), wound infection (3.8%), hematoma (3.8%), and symptomatic Frey's syndrome (1.7%). More extensive surgical procedures, including complete superficial or total parotidectomy, were associated with a 2.7 times greater incidence of immediate postoperative facial nerve weakness compared with partial superficial parotidectomy. CONCLUSION: Partial superficial parotidectomy is associated with a decreased incidence of transient postoperative facial nerve weakness compared with more extensive procedures such as complete superficial or total parotidectomy. Intraoperative frozen section was an accurate means of selecting patients for the partial superficial parotidectomy procedure. SIGNIFICANCE: Partial superficial parotidectomy is an effective method for treating benign tumors confined to the superficial lobe. (C) 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
引用
收藏
页码:788 / 792
页数:5
相关论文
共 19 条
  • [1] Parotidectomy: review of treatment and outcomes
    Bova, R
    Saylor, A
    Coman, WB
    [J]. ANZ JOURNAL OF SURGERY, 2004, 74 (07) : 563 - 568
  • [2] Bron LP, 1997, ARCH OTOLARYNGOL, V123, P1091
  • [3] Carvalho M B, 1999, Sao Paulo Med J, V117, P233
  • [4] Salivary gland neoplasms
    Day T.A.
    Deveikis J.
    Gillespie M.B.
    Joe J.K.
    Ogretmen B.
    Osguthorpe J.D.
    Reed S.G.
    Richardson M.S.
    Rossi M.
    Saini R.
    Sharma A.K.
    Stuart R.K.
    [J]. Current Treatment Options in Oncology, 2004, 5 (1) : 11 - 26
  • [5] The impact of malignant disease on facial nerve function after parotidectomy
    Ellingson, TW
    Cohen, JI
    Andersen, P
    [J]. LARYNGOSCOPE, 2003, 113 (08) : 1299 - 1303
  • [6] Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review
    Gooden, E
    Witterick, IJ
    Hacker, D
    Rosen, IB
    Freeman, JL
    [J]. JOURNAL OF OTOLARYNGOLOGY, 2002, 31 (06) : 351 - 354
  • [7] Parotidectomy for benign parotid disease at a university teaching hospital: Outcome of 963 operations
    Guntinas-Lichius, O
    Klussmann, JP
    Wittekindt, C
    Stennert, E
    [J]. LARYNGOSCOPE, 2006, 116 (04) : 534 - 540
  • [8] Subtotal parotidectomy: A 10-year review (1985 to 1994)
    Helmus, C
    [J]. LARYNGOSCOPE, 1997, 107 (08) : 1024 - 1027
  • [9] FACIAL-NERVE GRADING SYSTEM
    HOUSE, JW
    BRACKMANN, DE
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1985, 93 (02) : 146 - 147
  • [10] HUGO NE, 1973, SURG CLIN N AM, V53, P105